Our associate editor Dr. Laura Mertens (NL) talks to Prof. Seth Lerner (US) about the SWOG S1011 trial results he presented at UROonco23 in Gothenburg. This phase III surgical trial evaluates the benefit of a ‘standard’ versus ‘extended’ lymphadenectomy performed at the time of radical cystectomy for muscle invasive urothelial cancer.
